rehab upgrad neutral po
prior under-perform thesi reflect expect multi-year turnaround
djo/medtech acquisit close feb cyclic risk fabtech
weld segment prevent rehab med-tech revenu return
revenu growth much earlier expect area suffer
year underinvest deliveri issu invest work capit
new product launch highest number five year fabtech
cyclic weak shown y/i organ revenu declin margin
perform exceed expect estim reflect continu
fabtech revenu declin continu strong oper execut sum-of-the-part
analysi suggest multipl expans possibl howev med-tech peer
growth margin cfx overal leverag remain elev net-debt-to-ebitda
see rehab upgrad neutral rais price
object base ebitda target multipl line
multi-industri peer averag smid cap coverag prefer
hd suppli flowserv
margin-driven beat fabtech rev turn
adjust ep estim
consensu fabric technolog strong oper margin y/i
despit core revenu declin y/i versu estim med-tech djo
slightli better estim top line margin
better estim op better estim lower share
count lower tax rate lower interest expens combin ad upsid
rais adj ep y/i
manag maintain adjust ep guidanc versu prior
consensu rais adjust ep versu
prior consensu reflect lower revenu due entir weaker
macro backdrop fabtech higher ebitda margin ebitda
higher y/i
net dbt
rehab upgrad neutral
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
oper two busi segment
fabric technolog medic technolog
fabtech product includ weld equip
devic prevent rehabilit
consum approxim adjust
ebitda expos cyclic end market
med-tech approxim adjust ebitda
show oper improv earli
stage multi-year turnaround leverag
reason optim med-tech
return growth prevent rehab
med-tech segment compris two sub-seg prevent rehab
revenu reconstruct reconstruct grow double-
digit revenu pace time driven best-in-class product altiv
revers shoulder global howev prevent rehab struggl
under-invest deliveri issu sever year prevent rehab
return revenu growth much earlier expect make path
reinvest appear gain traction
prevent rehab suffer year deliveri servic issu colfax
invest work capit help improv suppli chain also ad
back-offic staff improv custom servic level ceo trerotola said
confer call definit gotten clear signal real custom
pain back half last year begin year mitig
work make thing better better time
prevent rehab new product launch highest number five
year med-tech strong channel posit within us clinic make new
product introduct somewhat easier reconstruct side individu
surgeon need train convert use new product ceo trerotola said
confer call invest growth health ramp new
product plan sure sustain return growth
restructur cost suggest med-tech margin tailwind
sinc acquir djo/medtech feb taken restructur
charg facil closur sever typic sever would
year payback facil closur would longer year payback use
assumpt allow in-year benefit suggest segment
margin expans howev portion save like use
fund new product invest view
forecast conserv histori
djo grew adjust ebitda compound-annual-growth-rate forecast compound-annual-growth-rate
see potenti upsid forecast assum organ
revenu growth compar manag
target hit pace assum adjust ebitda margin expans
line manag goal
chart forecast steadi improv
note data avail pro forma jan/feb result
fabtech still cyclic margin prove resili
colfax fabric technolog segment develop manufactur weld
consum electrod flux nozzl shield find global
manufactur pmi lead fab tech organ revenu growth quarter global
manufactur pmi averag suggest slight contract
last two month data shown uptick suggest trend may
bottom septemb august low juli
chart fab revenu trend follow pmi one-quart lag
fabtech saw soft european auto us oil ga broader industri end
market see downsid risk fab revenu last time
global manufactur pmi next six month
revenu declin y/i declin
fabtech averag adjust ebitda margin
expans period organ revenu flat volum
compound-annual-growth-rate price compound-annual-growth-rate margin expans balanc gross
margin gain sg reduct
forecast fabtech revenu declin y/i given decrement
margin environ wors expect would expect margin declin
sever
bull case share simpl ebitda come
segment peer current trade ebitda estim
remain ebitda remain cyclic fab segment
peer trade ebitda estim take blend averag suggest
multipl well cfx current multipl
fabtech cyclic broader multi-industri peer
segment revenu declin organ basi fabtech
exposur auto heavi vehicl oil ga infrastructur ship combin
revenu
med-tech peer revenu growth margin
forecast segment reach ebitda margin
would still leav peer manag y/i revenu target
segment compar peer averag y/i modestli slower
growth lower margin think assum discount orthoped peer
reason believ manag good handl lever necessari
improv revenu margin howev new product innov take longer
medic versu industri end market
base price object ev/ebitda estim prev
target multipl line multi-industri peer averag ev/ebitda
reflect higher financi leverag off-set defens portfolio
tabl select valuat metric peer
po
note estim per bloomberg consensu adjust asbesto
adj ep margin-driven upsid
adjust ep estim
consensu fabric technolog strong oper margin y/i
despit core revenu declin y/i versu estim med-tech djo
slightli better estim top line margin
better estim op better estim lower
share count lower tax rate lower interest expens combin ad
us mn except per share data
corpor
net incom attribut non-controlling interest
amort expens tax
base price object ev/ebitda multipl estim
target multipl line multi-industri peer upsid risk price object
faster organ growth better-than-expect abil take cost
accret portfolio acquisit downsid risk price object
global capital-expenditure cycl deterior particularli emerg market challeng
improv med-tech segment greater competit
base price object ev/ebitda estim would
put line multi-industri peer group averag argu line
multipl fair reflect above-averag ep growth off-set below-averag ebitda
risk po slow global industri product achiev expect
return organ invest acquisit slower-than-expect margin
po base appli ev/ebitda multipl estim
multipl would consist trade rang begin prior
energi cycl would put compani premium compar group
think warrant given above-averag ep growth upsid margin
downsid risk po reduct capit spend key end market
specif oil ga greater consolid flow control market may increas
competit reduc price across industri weaker anticip
po base appli ev/ebitda multipl
ebitda estim facil manag construct industri segment
respect target multipl line segment respect peer group
downsid risk price object competit pressur facil
mainten busi erod margin deterior na non-residenti
po base appli ev/ebitda multipl estim
line peer group valuat move one year view
fair given solid margin earn growth averag convers due
risk po may overpay deal pursuit diversifi
expand product portfolio lower capital-expenditure auto oil ga power gen
key end market uncertainti asbesto litig could overhang
cash flow greater consolid flow control market may increas
competit reduc price across industri
andrew obin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us multi-industrials/engin construct coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
